sr141716 has been researched along with Drug Abuse, Intravenous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burbach, JP; Gerrits, MA; Hoogveld, E; Lesscher, HM; van Ree, JM | 1 |
Cossu, G; Fattore, L; Fratta, W; Martellotta, CM | 1 |
2 other study(ies) available for sr141716 and Drug Abuse, Intravenous
Article | Year |
---|---|
Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoid Receptor Antagonists; Cannabinoids; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Movement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Reinforcement, Psychology; Rimonabant; Self Administration; Substance Abuse, Intravenous | 2005 |
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptors, Cannabinoid; Receptors, Drug; Reinforcement Schedule; Rimonabant; Self Administration; Substance Abuse, Intravenous | 2001 |